Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | CHF 0 | reported | |
| FY 2024 | 2024-12-31 | CHF 4,970,000 | reported | |
| FY 2023 | 2023-12-31 | CHF 7,038,000 | reported | |
| FY 2022 | 2022-12-31 | CHF 189,600,000 | reported | |
| FY 2021 | 2021-12-31 | CHF 9,754,000 | reported | |
| FY 2020 | 2020-12-31 | CHF 9,344,000 | reported | |
| FY 2019 | 2019-12-31 | CHF 20,383,000 | reported |
Molecular Partners AG · CIK 1745114 · Engraved from SEC EDGAR
Molecular Partners AG is the 98th largest of the 175 covered companies the SEC files under this code, by market cap. SIC 2836
Latest filing Aug 25, 2026
The ifrs-full concepts with the most facts on file for this company.
Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
| Fiscal year | Dividends | Buybacks | Total | Per share | Shares | Shares · yoy | of free cash flow |
|---|---|---|---|---|---|---|---|
| FY2024 | — | CHF 0.00 | CHF 0.00 | — | 40.36M sh | +11.0% | — |
| FY2023 | — | CHF 0.00 | CHF 0.00 | — | 36.35M sh | +0.9% | — |
| FY2022 | — | CHF 631.00K | CHF 631.00K | — | 36.04M sh | +11.6% |
| 0.5% |
| FY2021 | — | CHF 0.00 | CHF 0.00 | — | 32.29M sh | — | — |
| FY2020 | — | CHF 0.00 | CHF 0.00 | — | — | — | — |
No reported open-market purchases or sales in the last 12 months.
5 managers · Quarter ended Jun 30, 2026All holders ›
2